← Back to Search

Behavioral Intervention

Full study intervention for Chronic Obstructive Pulmonary Disease

N/A
Recruiting
Led By Robert Wu, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This trial aims to see if a new program of care for COPD patients works well and is liked by patients. The program includes virtual pulmonary rehabilitation, integrated care, and remote clinical monitoring.

Who is the study for?
This trial is for patients with COPD who were recently discharged after a severe flare-up and referred to Virtual Pulmonary Rehabilitation or Remote Clinical Monitoring at Toronto Grace Health Centre. It's not for those with other major lung diseases, very short life expectancy, or significant cognitive issues without caregiver support.Check my eligibility
What is being tested?
The CHARM-COPD program includes virtual pulmonary rehabilitation, integrated care, and remote monitoring using tools like the Hyfe Smartwatch, Home Spirometer, FitBit Versa 2, and audio recording to manage COPD after hospital discharge.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring devices and virtual programs rather than medications, typical drug side effects are not expected. However, participants may experience discomfort or inconvenience from wearing devices.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability by patients and clinicians
Actual usage over 90 days
Feasibility of the program and research study
Secondary outcome measures
Readmissions within 30 days

Trial Design

1Treatment groups
Experimental Treatment
Group I: Full study interventionExperimental Treatment4 Interventions
In addition to the standard of care at the institutions which includes virtual pulmonary rehabilitation, remote clinical monitoring and integrated care, patients will have the option to use the following interventions: FitBit wearable device with continuous monitoring for oxygen saturation and respiratory rate for 90 days Hyfe cough monitoring smartwatch with continuous monitoring for 90 days Home spirometer used once daily for 90 days Audio recordings on a tablet once daily for 90 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Audio recording
2020
Completed Phase 1
~130

Find a Location

Who is running the clinical trial?

University of TorontoOTHER
690 Previous Clinical Trials
1,019,543 Total Patients Enrolled
The Salvation Army Toronto Grace Health CentreUNKNOWN
University Health Network, TorontoLead Sponsor
1,476 Previous Clinical Trials
485,080 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are potential participants currently able to apply for enrollment in this research study?

"Indeed, the details on clinicaltrials.gov indicate that this investigation is presently seeking suitable participants. Originally posted on September 15th, 2023 and last revised on February 8th, 2024, the study aims to enroll a total of 100 individuals at a singular research site."

Answered by AI

What is the current number of individuals being recruited for participation in this clinical investigation?

"Indeed, the information on clinicaltrials.gov shows that this research is in the recruitment phase. The trial was first listed on September 15th, 2023 and most recently revised on February 8th, 2024. It aims to enroll a total of 100 participants at one designated site."

Answered by AI
~12 spots leftby Jun 2024